Evidence map›Paper›PMID 28962124›Full record

ArticleExperimental and therapeutic medicine2017

Allicin protects against H

Runxiao Lv, Lili Du, Chunwen Lu, Jinhui Wu, Muchen Ding, Chao Wang, Ningfang Mao, Zhicai Shi

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Orexin-A protects SH-SY5Y cells against HInternational journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Runxiao LvDepartment of Rehabilitation Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Lili DuDepartment of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning 110122, P.R. China.
Chunwen LuDepartment of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China.
Jinhui WuDepartment of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China.
Muchen DingDepartment of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China.
Chao WangDepartment of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China.
Ningfang MaoDepartment of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China.
Zhicai ShiDepartment of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China.
Changhai Hospital · CNSecond Military Medical University · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allicin is a major bioactive ingredient of garlic and has a broad range of biological activities. Allicin has been reported to protect against cell apoptosis induced by H

Indexed as

allicinapoptosisH2O2mitochondrial pathwayneuroprotectionPC12 cells

Identifiers

PMID28962124
PMCPMC5609123
OpenAlexW2724121703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.